Cargando…

Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID-19)

Detalles Bibliográficos
Autores principales:	Aleebrahim-Dehkordi, Elahe, Reyhanian, Ali, Hasanpour-Dehkordi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518362/ https://www.ncbi.nlm.nih.gov/pubmed/33042483 http://dx.doi.org/10.4103/ijpvm.IJPVM_145_20

Ejemplares similares

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2022)

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2023)

Investigating Neurological Manifestations of SARS-CoV-2
por: Mozafar, Maryam, et al.
Publicado: (2021)

The dilemmas of the classification of SARS-CoV-2 infection without clinical manifestations: Asymptomatic or presymptomatic
por: Arteaga-Livias, Kovy, et al.
Publicado: (2020)

NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection
por: Oliveira, Renato, et al.
Publicado: (2020)

Skin manifestations associated with the new coronavirus SARS-CoV-2 disease()
por: Redondo-Sendino, Áurea, et al.
Publicado: (2020)

Guillain–Barré syndrome as the first manifestation of SARS-CoV-2 infection
por: Barrachina-Esteve, O., et al.
Publicado: (2020)

Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
por: Sarode, Gargi S., et al.
Publicado: (2021)

Bilateral cystoid maculopathy as first manifestation of SARS-CoV-2 infection
por: Stanescu-Segall, D., et al.
Publicado: (2021)

SARS-CoV-2 and Acute Diverticulitis: the Expanding Gastrointestinal Manifestations of COVID-19 Infection
por: Weissman, Simcha, et al.
Publicado: (2021)

Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled type 2 diabetic patients
por: Emara, Mohamed H, et al.
Publicado: (2020)

Altered severity of the current SARS-CoV-2 in the Kurdistan region of Iraq
por: Hussein, Safin, et al.
Publicado: (2020)

Self-care Concept Analysis in Cancer Patients: An Evolutionary Concept Analysis
por: Hasanpour-Dehkordi, Ali
Publicado: (2016)

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort
por: Tubiana, Sarah, et al.
Publicado: (2021)

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
por: Ali, Nurshad
Publicado: (2020)

Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection()
por: Escalada Pellitero, S., et al.
Publicado: (2020)

Comment on: Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series
por: Finsterer, Josef
Publicado: (2022)

Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review
por: SHEIKHSHAHROKH, Amirhossein, et al.
Publicado: (2020)

Aerosolized SARS-CoV-2 transmission risk: Surgical or N95 masks?
por: Periyasamy, Petrick, et al.
Publicado: (2020)

Exposure history and molecular epidemiology of SARS-CoV-2: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2023)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report
por: Hassan, Muhammad, et al.
Publicado: (2021)

Identification of SARS-CoV-2 surface therapeutic targets and drugs using molecular modeling methods for inhibition of the virus entry
por: Farhadian, Sadegh, et al.
Publicado: (2022)

Detection of SARS-CoV-2 in ophthalmic secretions
por: Arshad, Yasir, et al.
Publicado: (2021)

Antimicrobial stewardship interventions to minimize healthcare worker exposure to SARS-CoV-2
por: Jones, K. Ashley, et al.
Publicado: (2020)

Rapid inactivation of SARS-CoV-2 after exposure to vapour hydrogen peroxide
por: Pottage, T., et al.
Publicado: (2021)

Could the SARS-CoV-2 infection be acquired from Smartphones?
por: Law, Siukan, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
por: Gulmez, Ali Osman, et al.
Publicado: (2023)

Mobile phones: A forgotten source of SARS-CoV-2 transmission
por: Ibrahim, Tony, et al.
Publicado: (2020)

Implication of nanotechnology-based approaches to combat SARS-CoV-2 infection
por: Heidari, Mana, et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
por: Chaves Filho, Adriano José Maia, et al.
Publicado: (2021)

Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
por: Asgarzdeh, Ali, et al.
Publicado: (2023)

Could the SARS-CoV-2 Infection be Acquired via the Eye?
por: Law, Siukan, et al.
Publicado: (2021)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6ukl4iokiji9cipo10knf3q6l